Trainimal (TRML) Q4 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 24/25 earnings summary
19 Jun, 2025Executive summary
Achieved positive EBITDA of 2.1 MSEK for the year, with net result nearly breakeven at -245 TSEK, reflecting successful cost reductions and margin improvements year-over-year.
Q4 saw increased revenue and profitability, with price hikes and new offerings boosting income and delivering a positive net result.
Membership margins reached 79.8% in Q4 and 74.3% for the year, with ARPU at 235 SEK/month.
English-language memberships launched, with marketing to begin in the coming year.
Financial highlights
Q4 net revenue: 3,118 TSEK (up from 2,917 TSEK year-over-year); full-year net revenue: 10,758 TSEK (down from 10,920 TSEK year-over-year).
Q4 operating income: 286 TSEK (vs. -565 TSEK); full-year operating income: -266 TSEK (vs. -1,010 TSEK).
Q4 EBITDA: 914 TSEK (vs. -22 TSEK); full-year EBITDA: 2,162 TSEK (vs. 916 TSEK).
Q4 net income before tax: 331 TSEK (vs. -585 TSEK); full-year: -245 TSEK (vs. -1,058 TSEK).
Q4 EPS: 0.14 SEK (vs. -0.25 SEK); full-year EPS: -0.10 SEK (vs. -0.45 SEK).
Outlook and guidance
Expecting modest start for English-language memberships, with confidence in product quality and pricing.
Marketing for English-language offerings to ramp up as resources allow.
Continued focus on cost control and margin improvement, with cautious marketing spend.
Latest events from Trainimal
- Q2 delivered robust sales growth, higher margins, and new medical partnerships, sustaining momentum.TRML
Q2 25/2619 Dec 2025 - Returned to profit in Q1 with higher margins, lower CAC, and strong cash flow.TRML
Q1 25/2619 Sep 2025 - EBITDA and subscription margins improved, with positive cash flow and global expansion plans.TRML
Q2 24/2513 Jun 2025 - Net sales and ARPU fell, but gross margin and recurring revenue stayed robust.TRML
Q1 24/2513 Jun 2025 - EBITDA turned positive and customer numbers hit a record after the new app launch.TRML
Q4 23/2413 Jun 2025 - Gross margin and EBITDA improved despite lower sales, with positive cash flow achieved.TRML
Q3 24/256 Jun 2025